Krystal Biotech (KRYS) Net Income (2016 - 2026)
Krystal Biotech's Net Income was $63.07 million in Q3 2026, down 20.5% from $79.37 million a year earlier but up 15.2% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Net Income (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Krystal Biotech's Net Income was $225.17 million through Sep 30, 2026, up 13.2% year-over-year; for FY2025, it came in at $204.83 million, up 129.7% from FY2024.
- In earlier years, Net Income was $89.16 million in FY2024 (+715.6%), $10.93 million in FY2023, -$139.98 million in FY2022 and -$69.57 million in FY2021.
- Quarterly Net Income has moved between -$49.97 million (Q1 2022) and $80.75 million (Q3 2023) over five years.
- Compared with a year earlier, Net Income was higher in six of the last seven quarters, with growth averaging 121.9%.
- The best year-over-year quarter for Net Income over five years was Q4 2024 (growth of 423.2%); the worst was Q3 2024 (a decline of 66.3%).
- Per Business Quant data, KRYS's Net Income in the three quarters before Q3 2026 was $54.77 million (Q2 2026), $55.93 million (Q1 2026) and $51.4 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 63.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 63.07 Mn |
| Jun 30, 2026 | 54.77 Mn |
| Mar 31, 2026 | 55.93 Mn |
| Dec 31, 2025 | 51.40 Mn |
| Sep 30, 2025 | 79.37 Mn |
| Jun 30, 2025 | 38.33 Mn |
| Mar 31, 2025 | 35.73 Mn |
| Dec 31, 2024 | 45.48 Mn |
| Sep 30, 2024 | 27.18 Mn |
| Jun 30, 2024 | 15.57 Mn |
| Mar 31, 2024 | 932,000.00 |
| Dec 31, 2023 | 8.69 Mn |
| Sep 30, 2023 | 80.75 Mn |
| Jun 30, 2023 | -33.21 Mn |
| Mar 31, 2023 | -45.30 Mn |
| Dec 31, 2022 | -32.05 Mn |
| Sep 30, 2022 | -29.85 Mn |
| Jun 30, 2022 | -28.11 Mn |
| Mar 31, 2022 | -49.97 Mn |
| Dec 31, 2021 | -21.81 Mn |
API Access
Krystal Biotech Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();